RRM2 and non-small cell lung carcinoma: Therefore, further investigation is necessary to evaluate using RRM2 as a molecular biomarker for NSCLC diagnosis, including increasing the sample size and scope, as well as determining the exact mechanism of the role of RRM2 in the development and progression of NSCLC.